Selenium

Selenium is a powerful mineral with antioxidant properties, which is needed in important processes in our body, such as thyroid function.

Benefits

Selenium contributes to:

• the protection of cells from oxidative stress.
• the normal function of the immune system.

Dosage

We included 20μg (36% NRV*).

Gobi Gold® mindset is to supplement your daily food intake. You can reach the daily recommended dose by eating:

• 90g of shrimps
• 100g of whole wheat pasta

Bioavailable Selenium Form

We use selenium in the form of selenomethionine in our formula, as it has superior absorption rate compared with other forms such as sodium selenite.

*NRV: Nutrient Reference Values (NRV) according to EU regulation No 1169/2011.

Read the evidence

Schnabel R, Lubos E, Messow CM, Sinning CR, Zeller T, Wild PS, Peetz D, Handy DE, Munzel T, Loscalzo J, Lackner KJ, Blankenberg S. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J. 2008 Dec;156(6):1201.e1-11. https://www.sciencedirect.com/science/article/abs/pii/S0002870308007898?via%3Dihub

Ventura, M., Melo, M., & Carrilho, F. (2017). Selenium and thyroid disease: From pathophysiology to treatment. International Journal of Endocrinology, 2017(January). https://doi.org/10.1155/2017/1297658

Hoffmann, Peter & Berry, Marla. (2008). The influence of selenium on immune responses. Molecular nutrition & food research. 52. 1273-80. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723386/

Backed up by science – Interested to learn more?

Schnabel R, Lubos E, Messow CM, Sinning CR, Zeller T, Wild PS, Peetz D, Handy DE, Munzel T, Loscalzo J, Lackner KJ, Blankenberg S. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J. 2008 Dec;156(6):1201.e1-11. PMID: 19033020; PMCID: PMC3624729 https://doi.org/10.1016/j.ahj.2008.09.004

Lubos, E.; Sinning, C.R.; Schnabel, R.B.; Wild, P.S.; Zeller, T.; Rupprecht,H.J.; Bickel, C.; Lackner, K.J.; Peetz, D.; Loscalzo, J.; Münzel, T.;Blankenberg, S. Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study. Atherosclerosis, 2010, 209, 271-277. https://doi.org/10.1016/j.atherosclerosis.2009.09.008

Köhrle, J., & Gärtner, R. (2009). Selenium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism, 23(6), 815–827. https://doi.org/10.1016/j.beem.2009.08.002

Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):804-10. doi: 10.1158/1055-9965.EPI-05-0950. PMID: 16614127.